Modulation of Contact System Proteases by Glycosaminoglycans
暂无分享,去创建一个
C. Hack | H. ten Cate | F. Citarella | H ten Cate | W A Wuillemin | E Eldering | F Citarella | C P de Ruig | C E Hack | W. Wuillemin | E. Eldering | C. P. de Ruig
[1] D. Beeler,et al. Interaction of factor XIa and antithrombin in the presence and absence of heparin. , 1986, Blood.
[2] J. Platt,et al. Role of heparan sulfate in immune system-blood vessel interactions. , 1993, Immunology today.
[3] J. Griffin,et al. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI. , 1983, The Journal of biological chemistry.
[4] R. Colman,et al. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. , 1982, The Journal of clinical investigation.
[5] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[6] I. Danishefsky,et al. Action of heparin on the inhibition of thrombin by alpha 1-proteinase inhibition. , 1983, Biochemistry.
[7] A. Schmaier,et al. Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor. , 1987, Archives of biochemistry and biophysics.
[8] D. Ausprunk,et al. Proteoglycans in the microvasculature. I. Histochemical localization in microvessels of the rabbit eye. , 1981, The American journal of pathology.
[9] C. Hack,et al. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor. , 1995, Blood.
[10] A. Poole. Proteoglycans in health and disease: structures and functions. , 1986, The Biochemical journal.
[11] A. Kaplan,et al. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes. , 1985, The Journal of biological chemistry.
[12] C. Forbes,et al. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. , 1970, The Journal of laboratory and clinical medicine.
[13] C. Hack,et al. A Novel Sensitive Assay for Functional Factor XII Based on the Generation of Kallikrein-C1-lnhibitor Complexes in Factor Xll-Deficient Plasma by Glass-Bound Factor XII , 1992, Thrombosis and Haemostasis.
[14] M. Silverberg,et al. The coagulation-kinin pathway of human plasma , 1987 .
[15] H. Gewurz,et al. Potentiation of C1-esterase inhibitor activity by heparin , 1976 .
[16] M. Schapira. Major Inhibitors of the Contact Phase Coagulation Factors , 1987, Seminars in thrombosis and hemostasis.
[17] H. Hemker,et al. Inhibition of factor XIa by antithrombin III. , 1987, Biochemistry.
[18] R. Carrell,et al. Heparin binding site, conformational change, and activation of antithrombin. , 1992, Biochemistry.
[19] K. Kurachi,et al. Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor). , 1977, Biochemistry.
[20] C. Hack,et al. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. , 1988, Blood.
[21] J. Potempa,et al. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.
[22] R. Colman. Surface-mediated defense reactions. The plasma contact activation system. , 1984, The Journal of clinical investigation.
[23] R. Colman,et al. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. , 1981, Biochemistry.
[24] Robert B Sim,et al. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s. , 1980, Biochimica et biophysica acta.
[25] R. Colman,et al. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. , 1982, The Journal of clinical investigation.
[26] C. Kitchens,et al. Factor XI: A Review of Its Biochemistry and Deficiency , 1991, Seminars in thrombosis and hemostasis.
[27] C. Hack,et al. Detection of Activation of the Contact System of Coagulation In Vitro and In Vivo: Quantitation of Activated Hageman Factor-C1-Inhibitor and Kallikrein-C1-Inhibitor Complexes by Specific Radioimmunoassays , 1987, Thrombosis and Haemostasis.
[28] Y. Komiyama,et al. A rapid enzyme-linked immunosorbent assay for human factor XI. , 1988, Thrombosis research.
[29] J. Meijers,et al. Inhibition of human blood coagulation factor XIa by C-1 inhibitor. , 1988, Biochemistry.
[30] J. Griffin,et al. Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen , 1983 .
[31] U. Lindahl,et al. Glycosaminoglycans and the regulation of blood coagulation. , 1993, The Biochemical journal.
[32] H. Saito,et al. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay. [/sup 125/I tracer technique] , 1977 .
[33] L. Kjellén,et al. Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.
[34] R. Colman,et al. The regulation of human factor XIIa by plasma proteinase inhibitors. , 1985, The Journal of biological chemistry.
[35] K. Fujikawa,et al. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. , 1986, Biochemistry.
[36] R. Colman,et al. Factors influencing the acceleration of human factor XIa inactivation by antithrombin III. , 1989, Blood.
[37] D. Spillmann,et al. More to "heparin" than anticoagulation. , 1994, Thrombosis research.
[38] R. Huber,et al. Proteinase — Protein inhibitor interactions , 1994 .
[39] A. Kaplan,et al. SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α1-Antitrypsin , 1974 .
[40] J. Marcum,et al. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. , 1984, The Journal of clinical investigation.
[41] R. Rosenberg,et al. Anticoagulant Action of Heparin , 1973, Nature.
[42] H. Saito,et al. Inhibitory spectrum of alpha 2-plasmin inhibitor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Oshima. The molecular-mass dependence of dextran sulfate enhancement of inactivation of thrombin and fibrinogen and on factor Xa neutralization by antithrombin III. , 1989, Biological chemistry Hoppe-Seyler.
[44] B. Faller,et al. Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha 1-proteinase inhibitor. , 1991, The Journal of biological chemistry.